4//SEC Filing
PHARMATHENE, INC 4
Accession 0001144204-15-046274
$ALTCIK 0001326190operating
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 7:19 PM ET
Size
5.5 KB
Accession
0001144204-15-046274
Insider Transaction Report
Form 4
Runge Jeffrey W.
Director
Transactions
- Award
Stock option (right to buy)
2015-08-02+20,000→ 20,000 totalExercise: $1.69From: 2016-08-02Exp: 2025-08-01→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The Issuer's Board of Directors approved the stock option grant on a non-trading day. On July 31, 2015, the last trading day prior to the date of grant, the closing price of the Issuer's common stock was $1.69 per share.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001326190
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 7:19 PM ET
- Size
- 5.5 KB